Evidence map›Paper›PMID 29682088›Full record

ArticleClinical epigenetics2018

Sabine A S Langie, Matthieu Moisse, Katarzyna Szarc Vel Szic, Ellen Van Der Plas, Gudrun Koppen, Sofie De Prins, Tijs Louwies, Vera Nelen, Guy Van Camp, Diether Lambrechts and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetics and Epigenetics in Asthma.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Sabine A S Langie1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.ORCID 0000-0003-3288-7331
Matthieu Moisse3Laboratory for Translational Genetics, Center for Cancer Biology, VIB and KU Leuven, Campus Gasthuisberg, Leuven, Belgium.
Katarzyna Szarc Vel Szic1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Ellen Van Der Plas1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Gudrun Koppen1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Sofie De Prins1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Tijs Louwies1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Vera NelenEnvironment and Health unit, Provincial Institute of Hygiene, Antwerp, Belgium.
Guy Van Camp6Center for Medical Genetics, University of Antwerp and Antwerp University hospital, Antwerp, Belgium.
Diether Lambrechts3Laboratory for Translational Genetics, Center for Cancer Biology, VIB and KU Leuven, Campus Gasthuisberg, Leuven, Belgium.
Greet Schoeters1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Wim Vanden Berghe4Proteinchemistry, Proteomics & Epigenetic Signaling (PPES), Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium.
Patrick De Boever1VITO- Sustainable Health, Boeretang 200, 2400 Mol, Belgium.
Flemish Institute for Technological Research · BEUniversity of Antwerp · BEVIB-KU Leuven Center for Cancer Biology · BEProvincial Institute for Hygiene · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of respiratory allergy in children is increasing. Epigenetic DNA methylation changes are plausible underlying molecular mechanisms. Results: Saliva samples collected in substudies of two longitudinal birth cohorts in Belgium (FLEHS1 & FLEHS2) were used to discover and confirm DNA methylation signatures that can differentiate individuals with respiratory allergy from healthy subjects. Genome-wide analysis with Illumina Methylation 450K BeadChips revealed 23 differentially methylated gene regions (DMRs) in saliva from 11y old allergic children (N=26) vs. controls (N=20) in FLEHS1. A subset of 7 DMRs was selected for confirmation by iPLEX MassArray analysis. First, iPLEX analysis was performed in the same 46 FLEHS1 samples for analytical confirmation of the findings obtained during the discovery phase. iPLEX results correlated significantly with the 450K array data ( Conclusion:

Indexed as

DNA MethylationBelgiumCase-Control StudiesChildChild, PreschoolCpG IslandsEpigenesis, GeneticFemaleGenome-Wide Association StudyHumansLongitudinal StudiesMaleNuclear ProteinsPromoter Regions, GeneticRespiratory HypersensitivitySalivaGLI2 protein, humanNuclear ProteinsZinc Finger Protein Gli2DNA methylationGLI2Illumina Methylation 450K BeadChipRespiratory allergySaliva

Identifiers

PMID29682088
PMCPMC5896137
OpenAlexW2803621926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.